Showing results (181-190 of 624) with videos related to

Sort By:
Pageof 63
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 1, 1996
A primary acoustic startle pathway: obligatory role of cochlear root neurons and the nucleus reticularis pontis caudalisY Lee, D E López, E G Meloni, et al.
The Journal of Biological Chemistry|December 15, 2005
Dual roles for the phosphatase PPM1D in regulating progesterone receptor functionDavid A Proia, Bonnie W Nannenga, Lawrence A Donehower, et al.
Advances in Experimental Medicine and Biology|January 1, 1981
Immunochemical characterization of Syrian hamster major histocompatibility complex homologuesJ T Phillips, J W Streilein, D A Proia, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|September 1, 1995
Biochemical indices may not accurately reflect changes in nutritional status after allogeneic bone marrow transplantationM Muscaritoli, L Conversano, C Cangiano, et al.
Haematologica|April 28, 2001
Molecular evaluation of the NUP98/RAP1GDS1 gene frequency in adults with T-acute lymphoblastic leukemiaG Cimino, T Sprovieri, M C Rapanotti, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1987
Recombinant interferon alpha-2 modulates hairy cell phenotype "in vitro"A Fattorossi, A Dolei, J G Pizzolo, et al.
Tumori|June 30, 1986
Unusual dermatologic toxicity of long-term therapy with hydroxyurea in chronic myelogenous leukemiaE Montefusco, G Alimena, R Gastaldi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Pharmacological purging of syngeneic bone marrow ex vivo: effect of treatment with doxorubicin and lonidamine on normal and leukaemic cells of DBA/2 miceA Sandrelli, P De Fabritiis, A Capua, et al.
European Journal of Haematology|March 1, 1989
Intermediate-dose (25 mg/m2) intravenous melphalan for patients with multiple myeloma in relapse or refractory to standard treatmentM T Petrucci, G Avvisati, M Tribalto, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1984
2-Methyl-9-hydroxyellipticinium acetate (ellipticinium) in the treatment of lymphomas. Preliminary results of a phase II studyS Tura, F Mandelli, P Mazza, et al.
Pageof 63